Shree Pacetronix will hold its 38th Annual General Meeting on September 29, 2026. The meeting is scheduled for 1:00 pm at the company's registered office in Pithampur, Madhya Pradesh.

The gathering addresses matters for the financial year ended March 31, 2026. The event will be conducted in physical mode.

Key Agenda Items

The AGM notice outlines several ordinary and special businesses for shareholder approval:

• Adoption of Financial Statements: Consideration and adoption of audited standalone and consolidated financial statements for FY26.
• Director Re-appointments: Re-appointment of Mr. Akash Sethi (DIN: 08176396) as Joint Managing Director for a further three-year term from August 14, 2027, to August 13, 2030. Additionally, re-appointment of Non-Executive Independent Directors Ms. Manali Tongia (DIN: 09542172) and Ms. Somya Chabbra (DIN: 09597296) for five-year terms.
• Auditor Appointment: Appointment of M/S. Agarwal Patel and Sinhal, Chartered Accountants, Indore (FRN: 012245C) as Statutory Auditors, replacing M/s. S. R. Naredi & Co., whose term expires. The new auditors will hold office until the conclusion of the 43rd AGM.
• Remuneration Increase: Approval for an increase in the remuneration of Joint Managing Director Mr. Akash Sethi, effective April 1, 2026. His basic salary is proposed to be up to ₹5,00,000 per month, with perquisites and allowances up to 50% of the basic salary.
• Related Party Transactions: Omnibus approval for material related-party transactions with subsidiary Shree Coratomic Limited, up to an aggregate amount of ₹10 crore for FY27. These transactions involve sale/purchase of goods, services, and hire charges on an arm's length basis.

Compliance and Disclosure

The company dispatched letters containing web-links to its annual report and AGM notice on September 5, 2026. This action complies with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

These communications target members whose email addresses are not registered with the Registrar and Share Transfer Agent or Depository Participants. Shareholders with registered emails received the documents electronically under Regulation 36(1)(a).

Accessing Documents

Shareholders can access the annual report and AGM notice via the company website. The documents are available at the investor corner section of the site.

Members seeking physical copies may write to the company with their folio or client IDs. The documents are also listed on the BSE Limited and CDSL websites.

Corporate Details

The company is celebrating 33 years of cardiac pacing technology. Its registered office is located in Sector-II, Industrial Area, Pithampur.

Akash Sethi, Promoter & Joint Managing Director of Shree Pacetronix Limited , has increased his stake in the company by acquiring 1,78,000 equity shares on June 08, 2026. The acquisition, executed through an off-market transfer from Bio Pace Technology INC, was disclosed to BSE Limited under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This transaction alters the shareholding structure of the target company, raising Sethi's ownership significantly.

Prior to the acquisition, Sethi held 3,28,471 shares carrying voting rights, which accounted for 8.76% of the total share capital. The recent purchase of 1,78,000 shares has increased his direct equity holding to 5,06,471 shares. This new figure represents 13.51% of the total voting capital of Shree Pacetronix Limited. The total equity share capital of the company remains at ₹ 3,74,97,000, consisting of 37,49,700 equity shares of ₹10 each fully paid.

Shareholding Details

The disclosure outlines the shift in ownership percentages before and after the transaction. The acquisition also impacts the diluted shareholding calculations, which include the conversion of warrants into equity shares. The total diluted share capital post-acquisition stands at ₹ 3,90,00,000, comprising 39,00,000 equity shares.

Regulatory Context

The transaction was completed via an off-market mechanism, distinct from open market operations or public issues. Sethi confirmed that there are no shares held in the nature of encumbrance such as pledge or lien, nor are there any voting rights held otherwise than by equity shares. The disclosure was submitted to the exchange on June 10, 2026, from Pithampur, Madhya Pradesh, to ensure compliance with regulatory norms governing substantial acquisitions.